There are currently 18 active clinical trials seeking participants for Venous Thromboembolism research studies. The states with the highest number of trials for Autism participants are Ontario, Florida, California and Texas.
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
NCT05891886
Recruiting
A study of how supplemental oxygen helps patients with acute pulmonary embolism (PE). Hypothesis: Oxygen affects right ventricular dysfunction (RVD) in patients with acute pulmonary embolism (PE) primarily by relieving hypoxic pulmonary vasoconstriction and reducing pulmonary pressure (PA) pressure, and that this process is metabolically driven.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/17/2023
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Pulmonary Embolism, Venous Thromboembolism, Metabolomics, Oxygen Inhalation Therapy
Register for Updates
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
NCT05351749
Recruiting
The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to prescribers. Furthermore, the researchers hypothesize that the availability of a pharmacist referral option is associated with a higher rate of prescription changes for initial-prescription alerts that are directed to the prescriber at the time of initial-prescribing errors. Findings from this project w... Read More
Gender:
All
Ages:
All
Trial Updated:
09/05/2023
Locations: University of Michigan, Ann Arbor, Michigan
Conditions: Pulmonary Embolism, Venous Thromboembolism, Atrial Fibrillation
Register for Updates
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer
NCT05240508
Recruiting
Thrombosis is common and contributes significantly to morbidity and mortality in patients with cancer. At least 20% of patients with cancer develop venous thromboembolism (VTE) and another 5% will experience acute arterial thromboembolism (ATE) due to cancer and its treatment. Current guidelines recommend VTE thromboprophylaxis in high-risk outpatients. Thromboprophylaxis strategies are inadequate as 50% of high-risk patients on prophylaxis still develop a VTE, the rate of recurrent VTE is ~24%... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/15/2023
Locations: University of Vermont Medical Center, Burlington, Vermont
Conditions: Venous Thromboembolism
Register for Updates
Warfarin Patient Self-management Implementation in the US Healthcare System
NCT04766216
Recruiting
In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/29/2023
Locations: VA Loma Linda Healthcare System, Loma Linda, California +3 locations
Conditions: Atrial Fibrillation, Venous Thromboembolism, Heart Valve Diseases
Register for Updates
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
NCT02464969
Recruiting
To assess the safety and descriptive efficacy of apixaban in pediatric subjects requiring anticoagulation for the treatment of a VTE.
Gender:
All
Ages:
Between 0 days and 17 years
Trial Updated:
02/06/2023
Locations: Pediatric Cardiology Clinic, Birmingham, Alabama +127 locations
Conditions: Venous Thromboembolism
Register for Updates
Filter Initial & Long Term Evaluation After Placement and Retrieval Registry
NCT01158482
Recruiting
A prospective data registry for all patients who undergo IVC (Inferior Vena Cava) filter placement or retrieval at Stanford. Potential enrollees will already be undergoing the procedure. If patients are willing, they will be prospectively enrolled prior to the procedure. As part of the study, chart and clinical data reviews will be used to track patient progress and response to the treatment.
Gender:
All
Ages:
All
Trial Updated:
05/09/2020
Locations: Stanford University School of Medicine, Stanford, California
Conditions: Venous Thromboembolism
Register for Updates